Our team combines world class science with industry experience

We are a team of scientists, doctors, healthcare experts, and industry professionals dedicated to win the fight against deadly infectious diseases.

We are the inventors of an antibiotic renewal technology to overcome antibiotic resistant bacteria for many generations to come.

We are also using our platform to develop new combinations of old antimicrobials that we hope can cure the disease known as COVID-19.

 

Senior Management

Prof Anthony Coates

Prof Anthony Coates

Founder & Chief Scientific Officer

James Phipson

James Phipson

Interim Chairman and CEO

Dr Yanmin Hu

Dr Yanmin Hu

Director Of Research

Erik van Kaathoven

Erik van Kaathoven

Chief Financial Officer

Board & Advisors

Dennis Molnar

Dennis Molnar

Non-Executive Director

Patrick Mocatta

Patrick Mocatta

Non-Executive Director

Rashmi H Barbhaiya

Rashmi H Barbhaiya

Chair, Scientific Advisory Committee

Mark J Goldberger

Mark J Goldberger

Member, Scientific Advisory Committee

George L Drusano

George L Drusano

Member, Scientific Advisory Committee

Dr Thomas Coates

Dr Thomas Coates

Medical Advisor

Annabel Watson

Annabel Watson

Investor Relations Advisor